Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $815.46 ($82K) on 2023-12-01, disclosed to the SEC on 2023-12-04.
Scheduled sale ($82k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $809.03 | 1 | $809 | 1.0% |
| 2 | $810.77 | 7 | $6K | 6.9% |
| 3 | $811.48 | 27 | $22K | 26.8% |
| 4 | $812.58 | 3 | $2K | 3.0% |
| 5 | $813.35 | 4 | $3K | 4.0% |
| 6 | $814.78 | 1 |
| $815 |
| 1.0% |
| 7 | $815.46 | 3 | $2K | 3.0% |
| 8 | $816.52 | 4 | $3K | 4.0% |
| 9 | $817.52 | 6 | $5K | 6.0% |
| 10 | $818.76 | 2 | $2K | 2.0% |
| 11 | $819.62 | 7 | $6K | 7.0% |
| 12 | $820.50 | 9 | $7K | 9.0% |
| 13 | $821.92 | 2 | $2K | 2.0% |
| 14 | $822.49 | 1 | $822 | 1.0% |
| 15 | $823.36 | 6 | $5K | 6.0% |
| 16 | $824.66 | 3 | $2K | 3.0% |
| 17 | $825.38 | 2 | $2K | 2.0% |
| 18 | $826.62 | 10 | $8K | 10.1% |
| 19 | $827.61 | 2 | $2K | 2.0% |
| Total | $817.30 avg | 100 | $82K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |